Literature DB >> 14991918

Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy.

Dario Paladini, Michele Vassallo, Maria Rosaria D'Armiento, Bruno Cianciaruso, Pasquale Martinelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991918     DOI: 10.1002/bdra.10147

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


× No keyword cloud information.
  5 in total

Review 1.  [Course and treatment of myasthenia gravis during pregnancy].

Authors:  J Klehmet; J Dudenhausen; A Meisel
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

Review 2.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

3.  Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature.

Authors:  Ingo Gottschalk; Christoph Berg; Nadia Harbeck; Rüdiger Stressig; Peter Kozlowski
Journal:  Breast Care (Basel)       Date:  2011-12-16       Impact factor: 2.860

Review 4.  Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

5.  Anti-inflammatory and immunosuppressive drugs and reproduction.

Authors:  Monika Østensen; Munther Khamashta; Michael Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew Czeizel; Jean Charles Piette; Ricard Cervera; Roger A Levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Journal:  Arthritis Res Ther       Date:  2006-05-11       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.